Pulmatrix Inc. (PULM)
9.06
-0.33 (-3.51%)
At close: Feb 20, 2025, 3:59 PM
9.01
-0.55%
After-hours: Feb 20, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 8.95 |
| Market Cap | 33.09M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -2.64 |
| PE Ratio (ttm) | -3.43 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 10.41 |
| Volume | 41,086 |
| Avg. Volume (20D) | 73,874 |
| Open | 9.51 |
| Previous Close | 9.39 |
| Day's Range | 8.81 - 9.59 |
| 52-Week Range | 1.55 - 10.40 |
| Beta | undefined |
About PULM
Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 21, 2014
Employees 22
Stock Exchange NASDAQ
Ticker Symbol PULM
Website https://www.pulmatrix.com
Analyst Forecast
According to 1 analyst ratings, the average rating for PULM stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
3 months ago
+73.66%
Pulmatrix shares are trading higher after the comp...
Unlock content with
Pro Subscription
